USA flag logo/image

An Official Website of the United States Government

Nanoparticle Defense for Agrichemical Exposures

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
Program Year/Program:
2012 / SBIR
Agency Tracking Number:
R43ES022125
Solicitation Year:
2012
Solicitation Topic Code:
NIEHS
Solicitation Number:
PA11-096
Small Business Information
ATERIS TECHNOLOGIES, LLC
910 Technology Blvd STE G Bozeman, MT 59718-
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2012
Title: Nanoparticle Defense for Agrichemical Exposures
Agency: HHS
Contract: 1R43ES022125-01
Award Amount: $158,919.00
 

Abstract:

DESCRIPTION (provided by applicant): This Phase I SBIR project seeks to develop specialized protein-polymer nanoparticles that are engineered to a therapeutic drug to counter the ill effects following exposure to organophosphate (OP) insecticides. The concept for these nanoparticles is based on 'customized, triggered-release' in which the membrane of a polymerized liposome nanoparticle (PLN) displays functional acetylcholinesterase, the primary target for OPs, while a therapeutic cargo is encapsulated (e.g., oxime). During an OP exposure, the AChE is inhibited (the same as exogenous ChE) to cause protein changes that later the polymeric nanoparticle membrane allowing the oxime cargo (various mechanisms possible) to be released and immediately available to restore exogenous ChE. Because the PLNs are customized and specific to OPs, PLN-AChE nanoparticles will not produce unwanted, high concentrations of the therapeutic agents in the body without OP exposure. In this application, we will develop and subsequentlyshow that AChE-PLNs can be generated with functional enzyme and are selectively inhibited by organophosphates (OP). We will further demonstrate that small molecule cargo can be loaded and stored in functional AChE-PLNs that reaction with OPs releases theentrapped cargo. We will produce 25 mg each of three functional, intact ChE-PLNs in readiness for the Phase II portion of this RandD project. PUBLIC HEALTH RELEVANCE: Citizens can be exposed to organophosphate (OP) insecticides via domestic application, aerial spraying, crops, as a pediculicide, and through the food chain. Accidental exposure to OP- containing pesticides can cause many tiers of toxicity, injury or be fatal to humans. For decades, only high-level exposures to OPs receive medical attention because low, chronic exposures have gone unchecked largely because they can asymptomatic, usually manifesting illnesses through accumulated exposures. If therapeutic measures could be available through a preventative process and highly specific toward OP exposures, a reduction in short- and long- term ill health effects could be expected.

Principal Investigator:

Jon O. Nagy
406-586-8420
jon.nagy@nagyconsult.com

Business Contact:

Charles M. Thompson
406-549-0675
charles.thompson@ateristech.com
Small Business Information at Submission:

ATERIS TECHNOLOGIES, LLC
910 Technology Blvd STE G Bozeman, MT 59718-

EIN/Tax ID: 156256873
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No